#1 Clinical Trials Search in Europe

Cefotaxime Sodium

This article discusses a clinical trial investigating the use of Cefotaxime Sodium, along with other antibiotics, in children with malignant brain tumors. The study aims to understand how these antibiotics behave in the body, particularly in the cerebrospinal fluid, to improve treatment for young patients with brain cancer.

Table of Contents

What is Cefotaxime Sodium?

Cefotaxime Sodium is an antibiotic medication used to treat various bacterial infections[1]. It belongs to a class of antibiotics called cephalosporins, which are effective against a wide range of bacteria. Cefotaxime Sodium is also known by its brand name Cefotaxim-MIP 1 g, which is available as a powder for making a solution for injection or infusion[1].

Medical Uses

Cefotaxime Sodium is primarily used to treat bacterial infections. While the specific details of its use are not provided in the given information, cephalosporins like Cefotaxime are generally used to treat a variety of infections, including:

  • Respiratory tract infections
  • Urinary tract infections
  • Skin and soft tissue infections
  • Bone and joint infections
  • Meningitis (infection of the brain and spinal cord membranes)

In the context of the clinical trial mentioned, Cefotaxime Sodium is being studied for its potential use in children with malignant brain tumors who may have or be at risk of leptomeningeal dissemination (spread of cancer cells to the membranes covering the brain and spinal cord)[1].

How is Cefotaxime Sodium Administered?

Cefotaxime Sodium is administered as a solution for injection or infusion[1]. This means it can be given in two ways:

  1. Intravenous infusion: The medication is slowly dripped into a vein over a period of time.
  2. Injection: The medication is directly injected into a vein or muscle.

The method of administration will depend on the specific condition being treated and the patient’s overall health status. Always follow your healthcare provider’s instructions on how to take this medication.

Current Clinical Trial

A clinical trial is currently being conducted to study the use of Cefotaxime Sodium and other antibiotics in children with malignant brain tumors[1]. This trial is classified as a Phase I clinical trial, which means it’s one of the earliest stages of testing a new treatment in humans.

The main objective of this trial is to measure the concentrations of different antibiotics, including Cefotaxime Sodium, in the cerebrospinal fluid (CSF) and plasma after intravenous or oral administration in children with malignant brain tumors[1]. CSF is the fluid that surrounds the brain and spinal cord.

Understanding Pharmacokinetics

The study focuses on the pharmacokinetics of antibiotics like Cefotaxime Sodium. Pharmacokinetics refers to how a drug moves through the body, including how it’s absorbed, distributed, metabolized, and excreted. In this study, researchers are particularly interested in:

  • How much of the antibiotic reaches the cerebrospinal fluid
  • How long the antibiotic stays in the body
  • How the concentration of the antibiotic changes over time

This information is crucial for determining the most effective dosing strategies for these antibiotics in children with brain tumors[1].

Eligibility Criteria for the Study

The study has specific criteria for who can participate. These include:

Inclusion Criteria:

  • Children aged 0 to 18 years (at the time of initial diagnosis)
  • Diagnosed with a brain tumor that has spread to the leptomeninges (the membranes covering the brain and spinal cord) or is at risk of doing so
  • Currently receiving antibiotic treatment (either intravenous or oral) for medical reasons
  • Undergoing intrathecal chemotherapy (chemotherapy delivered directly into the CSF) via an Ommaya reservoir (a special device implanted under the scalp)
  • Life expectancy of at least 8 weeks

Exclusion Criteria:

  • Not requiring antibiotic treatment or intrathecal therapy
  • Having conditions that make it unsafe to access the Ommaya reservoir or administer intrathecal chemotherapy
  • Pregnancy or breastfeeding

These criteria ensure that the study includes patients who can potentially benefit from the research while minimizing risks[1].

Study Endpoints

The study has several endpoints, which are the main results that the researchers will measure to determine if the treatment is effective. For Cefotaxime Sodium and other antibiotics in the study, these include:

  • How much of the antibiotic is present in the body over time (measured as the Area Under the Curve or AUC)
  • The concentration of the antibiotic at different time points during and after treatment
  • How well the antibiotic moves from the blood into the cerebrospinal fluid
  • How the concentration of the antibiotic in the CSF compares to the minimum amount needed to kill bacteria (known as the Minimum Inhibitory Concentration or MIC)
  • How long the antibiotic concentration in the CSF stays above the MIC

These measurements will help doctors understand how to best use Cefotaxime Sodium and other antibiotics in children with brain tumors, potentially improving treatment outcomes[1].

Aspect Details
Study Type Phase I clinical trial in patients
Main Objective Measure antibiotic concentrations in CSF and plasma of children with malignant brain tumors
Age Range 0-18 years
Key Inclusion Criteria CNS tumor with leptomeningeal dissemination, ongoing antibiotic treatment, intrathecal chemotherapy
Primary Endpoints AUC0-τ, AUC0-24, drug concentration at various time points, distribution from plasma to CSF
Secondary Endpoints AUC0-24/MIC ratio, %T>MIC, Cmax/MIC ratio, target attainment for relevant pathogens
Drug Information Cefotaxime Sodium, administered intravenously, pharmaceutical form: solution for injection/infusion

FAQ

  • What is the main goal of this clinical trial? The main goal is to measure the concentrations of different antibiotics, including Cefotaxime Sodium, in the cerebrospinal fluid and plasma of children with malignant brain tumors after administering the drugs intravenously or orally.
  • Who can participate in this study? The study is open to children aged 0 to 18 years with a central nervous system tumor that has spread to the lining of the brain and spinal cord (leptomeningeal dissemination) or is at risk of doing so. Participants must be currently receiving antibiotic treatment and intrathecal chemotherapy.
  • What is Cefotaxime Sodium? Cefotaxime Sodium is an antibiotic used to treat various bacterial infections. In this trial, it's being studied as part of a combination of antibiotics to understand its effectiveness in treating infections in children with brain tumors.
  • How is the medication given in this trial? The antibiotics, including Cefotaxime Sodium, are given either intravenously (through a vein) or orally (by mouth). The specific method depends on the patient's treatment plan.
  • What are the main things the researchers will be measuring? The researchers will be measuring how the antibiotics move through the body over time, looking at factors such as the area under the concentration-time curve, the concentration of the drug at different time points, and how well the drug moves from the blood into the cerebrospinal fluid.

Ongoing Clinical Trials on Cefotaxime Sodium

  • Study on Antibiotics Amoxicillin, Clavulanic Acid, Ciprofloxacin, and Drug Combination for Children with Malignant Brain Tumors

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria

Glossary

  • Cerebrospinal fluid (CSF): A clear, colorless fluid that surrounds the brain and spinal cord, protecting them from injury and providing nutrients.
  • Leptomeningeal dissemination: The spread of cancer cells to the thin layers of tissue (meninges) that cover the brain and spinal cord.
  • Pharmacokinetics: The study of how a drug moves through the body, including how it's absorbed, distributed, metabolized, and eliminated.
  • Intrathecal: Referring to the space under the arachnoid membrane of the brain or spinal cord, where cerebrospinal fluid circulates.
  • Ommaya reservoir: A small, dome-shaped device surgically implanted under the scalp that allows direct access to the cerebrospinal fluid for administering medication or removing fluid samples.
  • Minimum Inhibitory Concentration (MIC): The lowest concentration of an antibiotic that prevents visible growth of a bacterium.
  • Area Under the Curve (AUC): A measure of the total exposure to a drug over time, used to assess the effectiveness of the medication.

References

  1. http://clinicaltrials.eu/trial/study-on-antibiotics-amoxicillin-clavulanic-acid-ciprofloxacin-and-drug-combination-for-children-with-malignant-brain-tumors/